NasdaqGS - Nasdaq Real Time Price USD
Sight Sciences, Inc. (SGHT)
As of 1:33 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
79,395.00
81,056.00
71,331.00
48,956.00
27,640.00
Cost of Revenue
11,271.00
11,881.00
12,361.00
8,610.00
9,209.00
Gross Profit
68,124.00
69,175.00
58,970.00
40,346.00
18,431.00
Operating Expense
120,019.00
126,449.00
142,924.00
91,824.00
50,619.00
Operating Income
-51,895.00
-57,274.00
-83,954.00
-51,478.00
-32,188.00
Net Non Operating Interest Income Expense
-5,133.00
-5,408.00
-4,466.00
-4,366.00
-2,373.00
Other Income Expense
4,827.00
7,245.00
2,225.00
-6,928.00
-71.00
Pretax Income
-52,201.00
-55,437.00
-86,195.00
-62,772.00
-34,632.00
Tax Provision
120.00
110.00
47.00
188.00
61.00
Net Income Common Stockholders
-52,321.00
-55,547.00
-86,242.00
-62,960.00
-34,693.00
Diluted NI Available to Com Stockholders
-52,321.00
-55,547.00
-86,242.00
-62,960.00
-34,693.00
Basic EPS
-1.06
-1.14
-1.80
-2.36
-0.99
Diluted EPS
-1.06
-1.14
-1.80
-2.36
-0.99
Basic Average Shares
49,240.78
48,628.94
47,849.06
26,734.10
35,051.67
Diluted Average Shares
49,240.78
48,628.94
47,849.06
26,734.10
35,051.67
Total Operating Income as Reported
-51,895.00
-57,274.00
-83,954.00
-51,478.00
-32,188.00
Total Expenses
131,290.00
138,330.00
155,285.00
100,434.00
59,828.00
Net Income from Continuing & Discontinued Operation
-52,321.00
-55,547.00
-86,242.00
-62,960.00
-34,693.00
Normalized Income
-50,432.90
-55,547.00
-86,242.00
-62,960.00
-34,693.00
Interest Income
--
--
--
--
30.00
Interest Expense
5,133.00
5,408.00
4,466.00
4,366.00
2,403.00
Net Interest Income
-5,133.00
-5,408.00
-4,466.00
-4,366.00
-2,373.00
EBIT
-47,068.00
-50,029.00
-81,729.00
-58,406.00
-32,229.00
EBITDA
-46,371.00
-49,415.00
-81,019.00
-57,774.00
-31,675.00
Reconciled Cost of Revenue
11,271.00
11,881.00
12,361.00
8,610.00
9,209.00
Reconciled Depreciation
697.00
614.00
710.00
632.00
554.00
Net Income from Continuing Operation Net Minority Interest
-52,321.00
-55,547.00
-86,242.00
-62,960.00
-34,693.00
Total Unusual Items Excluding Goodwill
-2,390.00
--
--
--
--
Total Unusual Items
-2,390.00
--
--
--
--
Normalized EBITDA
-43,981.00
-49,415.00
-81,019.00
-57,774.00
-31,675.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-501.90
--
--
--
--
12/31/2020 - 7/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CTKB Cytek Biosciences, Inc.
4.9750
+0.61%
TMCI Treace Medical Concepts, Inc.
4.7400
+1.72%
VREX Varex Imaging Corporation
13.21
+0.61%
ITGR Integer Holdings Corporation
125.70
+1.17%
LUNG Pulmonx Corporation
6.63
+6.08%
RBOT-WS
BCCOY BICO Group AB (publ)
0.8819
0.00%
RXST RxSight, Inc.
51.20
+1.07%
BIIO Bionovate Technologies Corp
0.0001
0.00%
CVRX CVRx, Inc.
13.45
+2.52%